SOHM said that the pharmaceutical order is expected to drive revenue in 2010 and 2011 as future orders are delivered.
SOHM Inc Corporate Strategy vice president Shailesh Shah said that the potential for continued revenue growth in West Africa is very significant.
"We made a commitment to globalise our branded generic pharmaceutical product line and we are well on our way with our new partner in Africa," Shah said.
"There is a growing demand for lifestyle drugs such as Sildenafil citrate, which we will capitalise on with the SOHM brand."